1. Home
  2. NATL vs MYGN Comparison

NATL vs MYGN Comparison

Compare NATL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$40.25

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$6.52

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
MYGN
Founded
2023
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
625.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
NATL
MYGN
Price
$40.25
$6.52
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$42.75
$11.82
AVG Volume (30 Days)
382.1K
928.8K
Earning Date
11-05-2025
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.74
N/A
Revenue
$4,322,000,000.00
$825,300,000.00
Revenue This Year
$2.83
$0.08
Revenue Next Year
$3.96
$5.28
P/E Ratio
$22.05
N/A
Revenue Growth
0.63
0.21
52 Week Low
$22.30
$3.76
52 Week High
$42.23
$15.47

Technical Indicators

Market Signals
Indicator
NATL
MYGN
Relative Strength Index (RSI) 67.08 45.67
Support Level $36.63 $6.09
Resistance Level $39.22 $6.85
Average True Range (ATR) 0.96 0.27
MACD 0.03 0.01
Stochastic Oscillator 100.00 38.57

Price Performance

Historical Comparison
NATL
MYGN

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: